Atlas Trials

POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus

Clinical trial NCT02093598 · COMPLETED

Trial details

NCT number
NCT02093598
Sponsor
MedSIR
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, EndometrioidmTOR Protein
Start date
2012-05-01
Primary completion
2014-03-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.